5DK3

Crystal Structure of Pembrolizumab, a full length IgG4 antibody


Sequence Similarity Clusters for the Entities in PDB 5DK3

Entity #1 | Chains: A,F
Light Chain protein, length: 218 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 3 16616
95 % 2 3 17554
90 % 94 296 66
70 % 886 2682 2
50 % 2307 6927 1
40 % 2308 6928 1
30 % 2324 6975 1
Entity #2 | Chains: B,G
Heavy Chain protein, length: 444 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 49389
95 % 1 1 44423
90 % 1 1 42542
70 % 3 10 4684
50 % 4 27 1454
40 % 4 33 1084
30 % 4 33 1144

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6VI2 1 A, C FAB4 light chain 9606
2 6VI2 2 B, D FAB4 heavy chain 9606
3 4NZU 1 L 13PL heavy chain Fab 9606
4 4NZU 2 H 13PL light chain Fab 9606
5 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
6 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
7 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
8 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
9 1MEX 1 L Fab 29G12 light chain 10090
10 1MEX 2 H Fab 29G12 heavy chain 10090
11 6WFY 1 H Fab224 heavy chain 9606
12 6WFY 2 L Fab224 light chain 9606
13 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
14 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
15 4BUH 1 A, B CLONE M0418 SCFV 9606
16 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
17 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
18 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
19 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
20 6UCF 1 L N123-VRC34_pI4 light chain 9606
21 6UCF 2 H N123-VRC34_pI4 heavy chain 9606
22 5YD4 1 A, C, E, G scFv 4B08 10090
23 5YD3 1 A, C, E, G scFv 4B08 10090
24 6OC7 1 H Heavy chain of HMP42 Fab 9606
25 6OC7 2 L Light chain for HMP42 Fab 9606
26 5UD9 1 H Fab heavy chain 9606
27 5UD9 2 L Light chain 9606
28 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
29 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
30 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
31 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
32 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
33 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
34 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
35 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
36 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
37 6MEE 2 B, D antibody HEPC74 Light Chain 9606
38 6BJZ 1 H 5c8 Fab Heavy chain 9606
39 6BJZ 2 L 5c8 Fab Light chain 9606
40 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
41 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
42 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
43 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
44 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
45 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
46 4XCF 1 L 4E10 Fab light chain 9606
47 4XCF 2 H 4E10 Fab heavy chain 9606
48 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
49 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
50 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
51 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
52 6O24 1 A 4498 Fab heavy chain 9606
53 6O24 2 B 4498 Kappa light chain 9606
54 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
55 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
56 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
57 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
58 6UCE 1 L N123-VRC34_pI3 light chain 9606
59 6UCE 2 H N123-VRC34_pI3 heavy chain 9606
60 6Y1L 1 H FAB A.17 L47R mutant HEAVY CHAIN 9606
61 6Y1L 2 L FAB A.17 L47R mutant Light CHAIN 9606
62 5X08 1 H Fab 4E10 Heavy chain 9606
63 5X08 2 L Fab 4E10 Light chain 9606
64 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
65 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
66 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
67 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
68 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
69 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
70 6MEG 1 H antibody HEPC46 Heavy Chain 9606
71 6MEG 2 L antibody HEPC46 Light Chain 9606
72 5C2B 1 H scFv 3B4 9606
73 6O3K 1 L PGZL1.H4K3 light chain 9606
74 6O3K 2 H PGZL1.H4K3 heavy chain 9606
75 4XAW 1 L 4E10 Fab light chain 9606
76 4XAW 2 H 4E10 Fab heavy chain 9606
77 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
78 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
79 6WG8 1 A Dupilumab Fab heavy chain 9606
80 6WG8 2 B Dupilumab Fab light chain 9606
81 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
82 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
83 6TCR 1 H Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
84 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
85 5UCB 1 H Fab Heavy Chain 9606
86 5UCB 2 L Fab Light Chain 9606
87 2VXV 1 H HUMAN IGG ABT-325 9606
88 2VXV 2 L HUMAN IGG ABT-325 9606
89 6QF9 1 A, B scFv 9606
90 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
91 4GXV 1 H, I Antibody 1F1, heavy chain 9606
92 4GXV 2 L, M Antibody 1F1, light chain 9606
93 2VXT 1 H MURINE IGG 125-2H 10090
94 2VXT 3 L MURINE IGG 125-2H 10090
95 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
96 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
97 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
98 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
99 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
100 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
101 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
102 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
103 5W24 1 L 5C4 Fab Light Chain 10090
104 5W24 2 H 5C4 Fab Heavy Chain 10090
105 4HPY 1 H CH59 Fab heavy chain 9606
106 4HPY 2 L CH59 Fab light chain 9606
107 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
108 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
109 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
110 6XMI 1 A, D Fab Light chain 9606
111 6XMI 2 B, E Fab Heavy chain 9606
112 4JG1 1 L Fab light chain 9606
113 4JG1 2 H Fab heavy chain 9606
114 6E65 1 L TB31F Fab light chain 9606
115 6E65 2 H TB31F Fab heavy chain 9606
116 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
117 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
118 5VF2 1 A scFv 2D10 10090
119 5I8C 1 A VRC34.01 Fab heavy chain 9606
120 5I8C 2 B VRC34.01 Fab light chain 9606
121 4O5L 1 L Fab F045-092 light chain 9606
122 4O5L 2 H Fab F045-092 heavy chain 9606
123 5MYX 1 A, C Fab c#24 light chain 10090
124 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
125 3IFL 1 L 12A11 FAB antibody light chain 10090
126 3IFL 2 H 12A11 FAB antibody heavy chain 10090
127 5WK2 1 L M116 LIGHT CHAIN 9606
128 5WK2 2 H M116 HEAVY CHAIN FD 9606
129 3PP4 1 H GA101 Fab heavy chain 10090
130 3PP4 2 L GA101 Fab light chain 10090
131 3KDM 1 A, L Immunoglobulin light chain 9606
132 3KDM 2 B, H Immunoglobulin heavy chain 9606
133 5NIV 1 A Light chain of 5D3 Fab 10090
134 5NIV 2 B Heavy chain of 5D3 Fab 10090
135 6UG7 1 L ch28/11 Fab light chain 10090
136 6UG7 2 H ch28/11 Fab heavy chain 10090
137 5N4J 1 L LIGHT CHAIN 9606
138 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
139 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
140 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
141 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
142 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
143 5X4G 1 A 6H8 Fab heavy chain 10090
144 5X4G 2 B 6H8 Fab light chain 10090
145 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
146 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
147 4PTU 1 A Antibody pn132p2C05, light chain 9606
148 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
149 4TPR 1 L If kappa light chain 10090
150 4TPR 2 H Fab heavy chain 10090
151 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
152 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
153 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
154 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
155 3IFN 1 H 12A11 FAB antibody heavy chain 10090
156 3IFN 2 L 12A11 FAB antibody light chain 10090
157 5U3P 1 H DH511.4 Fab Heavy Chain 9606
158 5U3P 2 L DH511.4 Fab Light Chain 9606
159 6BLA 1 H AMM01 Fab Heavy chain 9606
160 6BLA 2 L AMM01 Fab Light chain 9606
161 4TOY 1 H 35O22 Fab Heavy chain 9606
162 4TOY 2 L 35O22 Fab Light chain 9606
163 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
164 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
165 3NPS 2 B S4 FAB HEAVY CHAIN 9606
166 3NPS 3 C S4 FAB LIGHT CHAIN 9606
167 5I4F 1 A scFv 2D10 10090
168 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
169 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
170 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
171 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
172 5WN9 1 H scFv 2D10 9606
173 4XC3 1 L 4E10 Fab light chain 9606
174 4XC3 2 H 4E10 Fab heavy chain 9606
175 4M5Y 1 H, I Fab 5J8 heavy chain 9606
176 4M5Y 2 L, M Fab 5J8 light chain 9606
177 4TQE 1 L If kappa light chain 10090
178 4TQE 2 H Fab heavy chain 10090
179 5YY4 1 A scFv 4B08 10090
180 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
181 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
182 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
183 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
184 6Q19 1 L Fab lambda chain 9606
185 6Q19 2 H Fab heavy chain 9606
186 6PDR 1 L antibody vFP25.18 light chain 10090
187 6PDR 2 H antibody vFP25.18 heavy chain 10090
188 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
189 5VSI 2 L CH1/Ckappa Fab light chain 9606
190 6NUY 1 L antibody M86 Fab arm light chain 10090
191 6NUY 2 H antibody M86 Fab arm heavy chain 10090
192 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
193 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
194 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
195 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
196 5JXA 1 H VRC03 Heavy chain 9606
197 5JXA 2 L VRC03 Light chain 9606
198 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
199 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
200 6QCU 1 L Light chain 9606
201 6QCU 2 H Heavy chain 9606
202 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
203 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
204 3NTC 1 L Fab light chain 10090
205 3NTC 2 H Fab heavy chain 10090
206 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
207 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
208 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
209 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
210 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
211 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
212 6PBV 1 A, C Fab668 light chain 9606
213 6PBV 2 B, D Fab668 heavy chain 9606
214 6PZG 1 L NA-80 Fab light chain 9606
215 6PZG 2 H NA-80 Fab heavy chain 9606
216 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
217 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
218 6BE3 1 H Fab (F598) Heavy Chain 9606
219 6BE3 2 L Fab (F598) Light Chain 9606
220 4NWU 1 H APE1551 Ab Fab heavy chain 9606
221 4NWU 2 L APE1551 Ab Fab light chain 9606
222 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
223 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
224 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
225 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
226 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
227 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
228 5EWI 1 H VRC38.01 Heavy Chain 9606
229 5EWI 2 L VRC38.01 Light Chain 9606
230 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
231 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
232 5E2W 1 L AT8 LIGHT CHAIN 10090
233 5E2W 2 H AT8 HEAVY CHAIN 10090
234 5MYK 1 A Fab c#17 light chain 10090
235 5MYK 2 B Fab c#17 heavy chain 10090
236 4NZR 1 H PGT135 heavy chain Fab 9606
237 4NZR 2 L PGT135 light chain Fab 9606
238 5MYO 1 A, C Fab c#6 light chain 10090
239 5MYO 2 B, D Fab c#6 heavy chain 10090
240 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
241 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
242 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
243 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
244 5UEL 1 H 354NC102 Fab Heavy Chain 9606
245 5UEL 2 L 354NC102 Fab Light Chain 9606
246 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
247 6WIY 1 H Fab 54-1G05 heavy chain 9606
248 6WIY 2 L Fab 54-1G05 light chain 9606
249 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
250 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
251 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
252 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
253 5E2V 1 L AT8 LIGHT CHAIN 10090
254 5E2V 2 H AT8 HEAVY CHAIN 10090
255 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
256 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
257 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
258 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
259 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
260 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
261 5JUE 1 L light chain of UIC2 Fab 10090
262 5JUE 2 H heavy chain of UIC2 Fab 10090
263 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
264 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
265 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
266 5JR1 1 H 10E8 heavy chain 9606
267 5JR1 2 L 10E8 mature light chain 9606
268 6CA7 1 L PCT64_13C light chain 9606
269 6CA7 2 H PCT64_13C heavy chain 9606
270 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
271 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
272 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
273 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
274 6MVL 2 H Antibody Fab fragment heavy chain 9606
275 6MVL 3 L Antibody Fab fragment light chain 9606
276 5OB5 2 H fAb Heavy chain 9606
277 5OB5 3 L fAb Light chain 9606
278 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
279 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
280 5I66 1 A 8B6 antibody, heavy chain 10090
281 5I66 2 B 8B6 antibody, light chain 10090
282 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
283 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
284 6WG0 1 H Fab366 heavy chain 9606
285 6WG0 2 L Fab366 light chain 9606
286 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
287 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
288 6BZY 1 H 22D11 Heavy Chain 10090
289 6BZY 2 L 22D11 Light Chain 10090
290 3QQ9 1 C, L 101F LIGHT CHAIN 10090
291 3QQ9 2 D, H 101F HEAVY CHAIN 10090
292 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
293 5TKK 3 L mouse antibody vFP5.01 light chain 10090
294 6PLH 1 A Fab 5G12 light chain 10090
295 6PLH 2 B Fab 5G12 heavy chain 10090
296 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
297 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
298 5W6C 1 H UCA Fab heavy chain 9606
299 5W6C 2 L UCA Fab light chain 9606
300 5I1K 1 L FAB LIGHT CHAIN 9606
301 5I1K 2 H FAB HEAVY CHAIN 9606
302 3OZ9 1 L Fab NC-1 kappa light chain 10090
303 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
304 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
305 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
306 5V7U 1 L CBTAU-22.1 Fab light chain 9606
307 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
308 5UEA 1 A, H Fab Heavy Chain 9606
309 5UEA 3 B, L Fab Light Chain 9606
310 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
311 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
312 6LTG 1 A, C antibody Fab fragment H-chain 10090
313 6LTG 2 B, D antibody Fab fragment L-chain 10090
314 3G5Y 1 A 175 light chain 10090
315 3G5Y 2 B 175 heavy chain 10090
316 5NMV 1 L Fab light chain 10088
317 5NMV 2 H Fab heavy chain 10088
318 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
319 4N8C 2 L, M Light chain of monoclonal antibody 10090
320 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
321 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
322 4HGW 1 A Antibody Fab fragment, light chain 10090
323 4HGW 2 B Antibody Fab fragment, heavy chain 10090
324 1NLB 1 L antibody 19D9D6 light chain 10090
325 1NLB 2 H antibody 19D9D6 heavy chain 10090
326 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
327 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
328 3VFG 1 L 3F8 Light Chain 10090
329 3VFG 2 H 3F8 Heavy Chain 10090
330 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
331 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
332 3QRG 1 L Fab light chain 9606
333 3QRG 2 H Fab heavy chain Fd fragment 9606
334 5M6A 1 A, B, C, D Bence-Jones light chain 9606
335 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
336 4LLY 2 B, D light chain Clambda 9606
337 6Y49 1 H A.17kappa antibody FAB fragment - Heavy Chain 9606
338 6Y49 2 L A.17kappa antibody FAB fragment - Light Chain 9606
339 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
340 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
341 5EZI 1 H Fab c12 heavy chain 9606
342 5EZI 2 L Fab c12 Light chain 9606
343 4K23 1 H anti-uPAR antibody, heavy chain 10090
344 4K23 2 L anti-uPAR antibody, light chain 10090
345 3NCJ 1 L Fab15 Mut8 light chain 9606
346 3NCJ 2 H Fab15 Mut8 heavy chain 9606
347 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
348 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
349 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
350 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
351 5W05 1 L M59 FAB LIGHT CHAIN 10090
352 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
353 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
354 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
355 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
356 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
357 4M61 1 A, C Fab A52 light chain 10090
358 4M61 2 B, D Fab A52 heavy chain 10090
359 5YE3 1 B 2A7D9 VH CH1 chain 10090
360 5YE3 2 A 2A7D9 L chain 10090
361 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
362 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
363 1UM5 1 L Antibody 21H3 L chain 10090
364 1UM5 2 H Antibody 21H3 H chain 10090
365 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
366 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
367 4NWT 1 L APE1531 Ab Fab light chain 9606
368 4NWT 2 H APE1531 Ab Fab heavy chain 9606
369 3WHX 1 A mAb Fab H fragment 10090
370 3WHX 2 B mAb Fab L fragment 10090
371 3NA9 1 L Fab15 light chain 9606
372 3NA9 2 H Fab15 heavy chain 9606
373 6Y1K 1 H FAB A.17 L47R mutant Heavy Chain 9606
374 6Y1K 2 L FAB A.17 L47R mutant Light Chain 9606
375 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
376 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
377 6RCO 1 A, C R5.004 heavy chain 9606
378 6RCO 2 B, D R5.004 light chain 9606
379 6VBO 1 L DH813 light chain 9606
380 6VBO 2 H DH813 heavy chain 9606
381 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
382 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
383 4LRI 1 A, B MSL-109 Light Chain 9606
384 4LRI 2 C, P MSL-109 Heavy Chain 9606
385 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
386 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
387 4JN2 1 A, L anti dabigatran Fab 10090
388 4JN2 2 B, H anti dabigatran Fab 10090
389 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
390 4XBE 2 H 4E10 Fab heavy chain 9606
391 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
392 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
393 6BE2 1 H Fab (F598) Heavy Chain 9606
394 6BE2 2 L Fab (F598) Light Chain 9606
395 4JFZ 1 L Fab light chain 9606
396 4JFZ 2 H Fab heavy chain 9606
397 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
398 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
399 3WIF 1 A mAb Fab H fragment 10090
400 3WIF 2 B mAb Fab L fragment 10090
401 5U6A 1 A Light Chain 9606
402 5U6A 2 B Heavy Chain 9606
403 6K0Y 1 A Antibody Heavy Chain 9606
404 6K0Y 2 B Antibody Light Chain 9606
405 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
406 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
407 3MBX 1 L X836 LIGHT CHAIN 10090
408 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
409 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
410 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
411 6PXR 1 L BIIB092 Fab (murine), light chain 10090
412 6PXR 2 H BIIB092 Fab (murine), heavy chain 10090
413 6APC 1 H Epididymis luminal protein 214 9606
414 6APC 2 L IGL@ protein 9606
415 6WOS 1 H Fab AR3B heavy chain 9606
416 6WOS 2 L Fab AR3B light chain 9606
417 4HHA 1 A Fab KE5 Fab fragment KE5 9606
418 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
419 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
420 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
421 4RGO 2 H 14G8 heavy chain Fab 10090
422 4RGO 3 L 14G8 light chain Fab 10090
423 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
424 5GRY 1 A, G diabody 9606
425 5UEK 2 H Fab 12E Heavy Chain 9606
426 5UEK 3 L Fab 12E Light Chain 9606
427 3NAA 1 L Fab15 Mut5 light chain 9606
428 3NAA 2 H Fab15 Mut5 heavy chain 9606
429 1Q0X 1 L Fab 9B1, light chain 10090
430 1Q0X 2 H Fab 9B1, heavy chain 10090
431 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
432 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
433 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
434 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
435 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
436 5IK3 2 B, D 1E03 Fab fragment light chain 9606
437 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
438 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
439 5XLI 1 a, b FabL 10090
440 5XLI 2 c, d FabH 10090
441 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
442 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
443 6DC4 1 H Fab AM22 Heavy Chain 9606
444 6DC4 2 L Fab AM22 Light Chain 9606
445 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
446 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
447 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
448 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
449 4WUK 1 H CH65 heavy chain 9606
450 4WUK 2 L CH65 light chain 9606
451 6WGK 1 A, C, E, G Dupilumab Fab heavy chain 9606
452 6WGK 2 B, D, F, H Dupilumab Fab light chain 9606
453 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
454 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
455 7JMP 2 H COVA2-39 heavy chain 9606
456 7JMP 3 L COVA2-39 light chain 9606
457 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
458 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
459 5JOP 1 D, L Fab 14.22 light chain 10090
460 5JOP 2 E, H Fab14.22 heavy chain 10090
461 4HPO 1 H CH58 Fab heavy chain 9606
462 4HPO 2 L CH58 Fab light chain 9606
463 6VLN 1 H 4498 Fab heavy chain 9606
464 6VLN 2 L 4498 Fab light chain 9606
465 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
466 5UKN 2 L DH522UCA Fab fragment light chain 9544
467 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
468 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
469 5IT2 1 H heavy chain 9606
470 5IT2 2 L light chain 9606
471 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
472 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
473 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
474 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
475 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
476 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
477 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
478 5MO3 3 L Fab of monoclonal antibody, light chain 10090
479 6L8T 1 B, D, L Antibody light chain 9606
480 6L8T 2 A, C, H Antibody heavy chain 9606
481 5GZ0 1 A, C FM329 light chain 1383439
482 5GZ0 2 B, D FM329 heavy chain 1383439
483 6DW2 1 A 6078 Fab light chain 9606
484 6DW2 2 B 6078 Fab heavy chain 9606
485 6SS0 1 HHH, III Fab C0021181 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
486 6SS0 2 LLL, MMM Fab C0021181 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
487 6MG4 1 A, B JTO light chain 9606
488 6BQB 1 L MGG4 Fab light chain 9606
489 6BQB 2 H MGG4 Fab heavy chain 9606
490 4PUB 1 H DX-2930 HEAVY CHAIN 9606
491 4PUB 2 L DX-2930 LIGHT CHAIN 9606
492 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
493 6B14 2 L Light chain of Fab BL3-6S97N 10090
494 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
495 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
496 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
497 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
498 5GS3 1 A, H diabody protein 9606
499 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
500 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
501 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
502 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
503 5VKD 2 H Fab Heavy Chain 9606
504 5VKD 3 L Fab light chain 9606
505 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
506 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
507 5XHG 1 A, C polypeptide(L) 10090
508 5XHG 2 B, D polypeptide(H) 10090
509 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
510 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
511 3UYR 1 H antibody Fab heavy chain 10090
512 3UYR 2 L antibody Fab light chain 10090
513 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
514 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
515 6UOE 1 H 3-25 Fab heavy chain 9606
516 6UOE 2 L 3-25 Fab light chain 9606
517 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
518 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
519 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
520 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
521 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
522 3OAZ 2 K, L Fab 2G12, light chain 9606
523 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
524 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
525 1ZAN 1 L Fab AD11 Light Chain 10116
526 1ZAN 2 H Fab AD11 Heavy Chain 10116
527 6CJK 1 A, C Immunoglobulin Fab light chain 9986
528 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
529 4N0Y 1 H IGH526 Heavy Chain 9606
530 4N0Y 2 L IGH526 Light Chain 9606
531 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
532 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
533 6OTC 2 H sFab H3 heavy chain 32630
534 6OTC 3 L sFab H3 light chain 32630
535 6Q1G 1 L H1244 Fab lambda chain 9606
536 6Q1G 2 H H1244 Fab heavy chain 9606
537 5MTH 1 A, H antibody Fab heavy chain 10090
538 5MTH 2 B, L antibody Fab light chain 10090
539 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
540 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
541 6O26 1 A 3246 Fab heavy chain 9606
542 6O26 2 B 3246 Fab light chain 9606
543 1RZF 1 L Fab E51 light chain 9606
544 1RZF 2 H Fab E51 heavy chain 9606
545 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
546 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
547 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
548 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
549 6WJ0 1 H Fab 54-4H03 heavy chain 9606
550 6WJ0 2 L Fab 54-4H03 light chain 9606
551 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
552 4KTE 2 L GE148 Light Chain Fab 9544
553 5I8O 1 H HMM5 antibody heavy chain 9606
554 5I8O 2 L HMM5 antibody light chain 9606
555 4JG0 1 L Fab light chain 9606
556 4JG0 2 H Fab heavy chain 9606
557 6LKT 1 A antibody Fab fragment H chain 10090
558 6LKT 2 B antibody Fab Fragment L-chain 10090
559 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
560 4YGV 2 B, L aDabi-Fab2a light chain 9606
561 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
562 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
563 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
564 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
565 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
566 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
567 3EO0 1 A, C GC-1008 Fab Light Chain 10090
568 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
569 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
570 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
571 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
572 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
573 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
574 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
575 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
576 6TCO 2 B, H Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
577 4FQI 3 H antibody CR9114 heavy chain Fab 9606
578 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
579 6KX1 1 A Fab Fragment-SN-101-Heavy chain 10090
580 6KX1 2 B Fab Fragment-SN-101-Light chain 10090
581 6S5A 2 H anti P329G LALA Fab heavy chain 10090
582 6S5A 3 L anti P329G LALA Fab light chain 10090
583 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
584 4JHA 2 L D25 light chain 9606
585 6SS5 1 HHH Fab C0020187 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
586 6SS5 2 LLL Fab C0020187 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
587 6B9Z 1 A Trastuzumab Fab light chain 10090
588 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
589 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
590 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
591 4PTT 1 A Antibody pn132p2C05, light chain 9606
592 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
593 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
594 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
595 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
596 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
597 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
598 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
599 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
600 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
601 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
602 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
603 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
604 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
605 4DGV 1 H HCV1 Heavy Chain Fab 9606
606 4DGV 2 L HCV1 Light Chain 9606
607 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
608 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
609 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
610 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
611 5TH2 1 A, C cetuximab Fab, light chain 10090
612 5TH2 2 B, D cetuximab Fab, heavy chain 10090
613 5I8K 1 L HHH1 Fab Light chain 9606
614 5I8K 2 H HHH1 Fab Heavy chain 9606
615 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
616 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
617 6ULF 1 A 4498 Fab heavy chain 9606
618 6ULF 2 B 4498 Fab light chain 9606
619 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
620 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
621 1YNL 1 L Ig gamma light chain 10090
622 1YNL 2 H Ig gamma heavy chain 10090
623 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
624 5EPM 2 B, F Antibody Fab fragment light chain 10090
625 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
626 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
627 3UMT 1 A scFv heavy chain and light chain 10090
628 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
629 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
630 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
631 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
632 6UC5 1 H Fab397 heavy chain 9606
633 6UC5 2 L Fab397 light chain 9606
634 6PEC 1 L antibody light chain 9544
635 6PEC 2 H antibody heavy chain 9544
636 6VJT 1 H Heavy Chain Fab Fragment of Monoclonal Ab15 9606
637 6VJT 2 L Light Chain Fab Fragment of Monoclonal antibody A15 9606
638 4NUJ 1 A PGT152 light chain 9606
639 4NUJ 2 B PGT152 heavy chain 9606
640 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
641 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
642 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
643 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
644 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
645 3U2S 2 B, L PG9 light chain 9606
646 6PE7 1 H FAB Heavy Chain 9606
647 6PE7 2 L FAB Light chain 9606
648 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
649 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
650 6KS2 1 A, C Fab7881 Light Chain (FabL) 10090
651 6KS2 2 B, D Fab7881 Heavy Chain (FabH) 10090
652 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
653 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
654 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
655 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
656 4NUG 1 L PGT151 light chain 9606
657 4NUG 2 H PGT151 heavy chain 9606
658 7BZ5 2 H Heavy chain of B38 9606
659 7BZ5 3 L Light chain of B38 9606
660 3IU4 1 H chP3 Fab heavy chain 10090
661 3IU4 2 L chP3 Fab light chain 10090
662 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
663 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
664 6WYT 1 H MuSK1B heavy chain Fab 9606
665 6WYT 2 L MuSK1B light chain Fab 9606
666 6DC8 1 L IgG light chain 10090
667 6DC8 2 H IgG heavy chain 10090
668 6NYQ 1 L 1H3 Fab light chain 10090
669 6NYQ 2 H 1H3 Fab heavy chain 10090
670 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
671 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
672 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
673 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
674 6IAS 1 H Fab NKp46-1 heavy chain 32630
675 6IAS 2 L Fab NKp46-1 light chain 32630
676 1P7K 1 A, L antibody light chain FAB 10090
677 1P7K 2 B, H antibody heavy chain FAB 10090
678 6WYR 1 L, M MuSK1A light chain Fab 9606
679 6WYR 2 H, I MuSK1A heavy chain Fab 9606
680 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
681 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
682 3RVV 2 C 4C1 - light chain 10090
683 3RVV 3 D 4C1 - heavy chain 10090
684 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
685 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
686 3P0Y 2 H Fab DL11 heavy chain 9606
687 3P0Y 3 L Fab DL11 light chain 9606
688 4NPY 1 A, L germline PGT121 light chain Fab 9606
689 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
690 6ANA 2 H LL2 Fab Heavy Chain 10090
691 6ANA 3 L LL2 Fab Light Chain 10090
692 5IBU 1 B, L 6652 Light Chain 9606
693 5IBU 2 G, H 6652 Heavy Chain 9606
694 5VPL 2 C 4C1 - LIGHT CHAIN 10090
695 5VPL 3 D 4C1 - HEAVY CHAIN 10090
696 6AOD 1 A FXIa Antibody FAB Light Chain 9606
697 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
698 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
699 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
700 2YPV 2 H FAB 12C1 10090
701 2YPV 3 L FAB 12C1 10090
702 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
703 6TCM 2 H Omalizumab Fab Omalizumab Fab heavy chain 9606
704 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
705 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
706 4JY5 1 L PGT122 light chain Fab 9606
707 4JY5 2 H PGT122 heavy chain Fab 9606
708 6ELE 1 A, H fAB heavy chain 9606
709 6ELE 2 B, L fAB light chain 9606
710 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
711 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
712 6B5R 1 H CIS42 Fab Heavy chain 9606
713 6B5R 2 L CIS42 Fab Light chain 9606
714 3NAC 1 L Fab15 Mut7 light chain 9606
715 3NAC 2 H Fab15 Mut7 heavy chain 9606
716 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
717 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
718 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
719 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
720 1Q72 1 L Fab M82G2, Light chain 10090
721 1Q72 2 H Fab M82G2, Heavy chain 10090
722 6XCA 1 H C105 Heavy Chain 9606
723 6XCA 2 L C105 Light Chain 9606
724 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
725 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
726 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
727 6MNQ 3 L Ab DH727.2 light chain 9544
728 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
729 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
730 4YHO 1 H aDabi-Fab3 heavy chain 9606
731 4YHO 2 L aDabi-Fab3 light chain 9606
732 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
733 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
734 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
735 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
736 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
737 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
738 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
739 4DGY 1 H HCV1 Heavy Chain Fab 9606
740 4DGY 2 L HCV1 Light Chain 9606
741 5EN2 1 A GD01 heavy chain 10090
742 5EN2 2 B GD01 light chain 10090
743 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
744 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
745 6P4Y 1 H 4A10 Fab heavy chain 10090
746 6P4Y 2 L 4A10 Fab light chain 10090
747 3MXW 2 L 5E1 light chain 9606
748 3MXW 3 H 5E1 heavy chain 9606
749 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
750 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
751 3EO9 1 L Efalizumab Fab fragment, light chain 9606
752 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
753 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
754 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
755 6N35 1 K, L Fab 2G12 light chain 9606
756 6N35 2 H, M Fab 2G12 heavy chain 9606
757 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
758 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
759 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
760 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
761 5WUV 1 L light chain 9606
762 5WUV 2 H heavy chain 9606
763 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
764 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
765 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
766 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
767 4JM4 1 H PGT 135 Heavy Chain Fab 9606
768 4JM4 2 L PGT 135 Light Chain Fab 9606
769 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
770 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
771 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
772 5YE4 2 B, D 1A9D7 L chain 10090
773 6B0G 1 C 1245 Antibody, Light Chain 9606
774 6B0G 2 D 1245 Antibody, Heavy Chain 9606
775 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
776 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
777 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
778 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
779 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
780 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
781 6D0X 1 A 2140 Antibody, heavy chain 9606
782 6D0X 2 B 1210 Antibody, light chain 9606
783 6UUD 1 H 5D5 Antibody Fab, heavy chain 10090
784 6UUD 2 L 5D5 Antibody Fab, light chain 10090
785 6BE4 1 H Fab (F598) Heavy Chain 9606
786 6BE4 2 L Fab(F598) Light Chain 9606
787 5TPP 1 L DH270.5 Fab heavy chain 9606
788 5TPP 2 H DH270.5 Fab light chain 9606
789 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
790 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
791 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
792 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
793 6P7H 1 B Antibody DF2F-b.04 light chain 9479
794 6P7H 2 A Antibody DF2F-b.04 heavy chain 9479
795 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
796 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
797 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
798 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
799 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
800 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
801 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
802 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
803 5TL5 1 L M2177 LIGHT CHAIN 10090
804 5TL5 2 H M2177 HEAVY CHAIN 10090
805 2FX7 1 L Fab 4E10 Light Chain 9606
806 2FX7 2 H Fab 4E10 Heavy Chain 9606
807 6O39 1 A Antibody F2.I Fab, Light chain 9606
808 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
809 5Y9K 1 L belimumab light chain 9606
810 5Y9K 2 H belimumab heavy chain 9606
811 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
812 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
813 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
814 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
815 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
816 6GLW 3 D, L Fab 1D11 - Light chain 9844
817 3WFH 1 A mAb Fab H fragment 10090
818 3WFH 2 B mAb Fab L fragment 10090
819 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
820 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
821 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
822 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
823 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
824 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
825 6WFZ 1 A, H Fab399 heavy chain 9606
826 6WFZ 2 B, L Fab399 light chain 9606
827 6GKU 2 H Fab 6F5 - Heavy Chain 9844
828 6GKU 3 L Fab 6F5 - Light chain 9844
829 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
830 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
831 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
832 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
833 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
834 5HI4 3 D, L CAT-2000 FAB light chain 9606
835 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
836 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
837 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
838 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
839 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
840 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
841 3RVW 2 C 4C1 - light chain 10090
842 3RVW 3 D 4C1 - heavy chain 10090
843 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
844 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
845 5XKU 2 B HNIgGA6 light chain 9606
846 5XKU 3 C HNIgGA6 heavy chain 9606
847 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
848 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
849 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
850 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
851 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
852 5HI5 3 D, L CAT-2000 light chain 9606
853 5JO5 1 A, C, E, H 10E8 gHV 9606
854 5JO5 2 B, D, F, L 10E8 gLV 9606
855 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
856 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
857 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
858 5CCK 2 L Antibody 3BC315 Fab light chain 9606
859 6GXX 1 H FAB 1D9 heavy chain 10090
860 6GXX 2 L FAB 1D9 light chain 10090
861 6JP7 1 H immunoglobulin Fab heavy chain 9606
862 6JP7 2 L immunoglobulin Fab light chain 9606
863 5I76 1 A, C FM318_light_chain 1383439
864 5I76 2 B, D FM318_heavy_cahin 1383439
865 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
866 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
867 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
868 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
869 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
870 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
871 5I18 1 L FAB LIGHT CHAIN 9606
872 5I18 2 H FAB HEAVY CHAIN 9606
873 6QB3 2 X scFv55 9606
874 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
875 4JN1 2 L anti-dabigatran Fab1, light chain 10090
876 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
877 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
878 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
879 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
880 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
881 4G5Z 2 L canakinumab antibody fragment light chain 9606
882 6W00 2 L Fab239 light chain 9606
883 6W00 3 H Fab239 heavy chain 9606
884 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
885 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
886 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
887 6SF6 1 A, H COMP-reactive monoclonal antibody 15A Fab fragment, heavy chain 10090
888 6SF6 2 B, L COMP-reactive monoclonal antibody 15A Fab fragment, light chain 10090
889 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
890 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
891 2OK0 2 L Fab ED10 light chain 10090
892 2OK0 3 H Fab ED10 heavy chain 10090
893 6P4C 1 L HyHEL10 Fab light chain 10090
894 6P4C 2 H HyHEL10 Fab heavy chain 10090
895 3SOB 1 L antibody light chain 9606
896 3SOB 3 H antibody heavy chain 9606
897 6UG8 1 L ch28/11 Fab light chain 10090
898 6UG8 2 H ch28/11 Fab heavy chain 10090
899 6B5M 1 H CIS43 Fab Heavy chain 9606
900 6B5M 2 L CIS43 Fab Light chain 9606
901 5AWN 1 H Heavy chain of 3BC176 Fab 9606
902 5AWN 2 L Light chain of 3BC176 Fab 9606
903 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
904 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
905 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
906 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
907 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
908 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
909 5DR5 2 L AbD09097 Fab light chain 9606
910 6MG5 1 A, B Light chain JTO 9606
911 2IH3 1 A FAB Heavy Chain 10090
912 2IH3 2 B FAB Light Chain 10090
913 4KQ3 1 L CNTO3186 light chain Fab 9606
914 4KQ3 2 H CNTO3186 heavy chain Fab 9606
915 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
916 6AQ7 3 L POM6 FAB light CHAIN 10090
917 4JFX 1 A, L Fab light chain 9606
918 4JFX 2 B, H Fab heavy chain 9606
919 3SGE 1 I, L Light Chain 10090
920 3SGE 2 H, J Heavy Chain 10090
921 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
922 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
923 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
924 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
925 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
926 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
927 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
928 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
929 5FHB 1 H Antibody 100 Fab heavy chain 9606
930 5FHB 2 L Antibody 100 Fab light chain 9606
931 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
932 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
933 1JGU 1 L Antibody Light Chain 10090
934 1JGU 2 H Antibody Heavy Chain 10090
935 4I77 1 H Lebrikizumab heavy chain Fab 9606
936 4I77 2 L Lebrikizumab light chain Fab 9606
937 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
938 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
939 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
940 4O4Y 2 H 2095-2 heavy chain 9986
941 5OBF 1 H fAb Heavy chain 10090
942 5OBF 2 L fAb Light chain 10090
943 6QNK 1 A, C FAB light chain 10090
944 6QNK 2 B, D FAB heavy chain 10090
945 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
946 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
947 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
948 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
949 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
950 1DQQ